ArticleComputers in biology and medicine2025
Monte Carlo Tree Search for optimal cancer intervention strategies among BRCA mutation carriers.
Article in Computers in biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Breast and ovarian cancers are the second and fifth leading causes of cancer-related death among women in the United States. Compared to non-carriers, BRCA mutation carriers are subject to a higher risk of developing breast and ovarian cancers. Prophylactic surgeries including prophylactic mastectomy and prophylactic bilateral salpingo-oophorectomy can significantly reduce the incidence risks of breast and ovarian cancers for BRCA mutation carriers. However, both prophylactic surgeries are permanent one-time interventions. Determining the optimal age for BRCA carriers to undergo such surgeries is critical. The optimal solution depends on sequential decision-making over long periods during a patient's life involving the cancer incidence risk and quality of life (QOL). Thus, there is an urgent need to develop an optimal cancer intervention strategy with the goal to reduce cancer risk and maintain a high-level QOL. This paper presents a novel sequential decision-making framework for BRCA mutation carriers by jointly considering the two objectives. We first propose to model the dynamic progression of cancer risk using a continuous-time Markov Decision Process. Second, we propose to solve for the optimal intervention strategies through Monte Carlo Tree Search (MCTS) by optimally balancing the exploitation of current knowledge and exploration of uncertainty factors about the cancer state. Experimental results show that the proposed MCTS planning method can effectively provide optimal sequential intervention strategies for BRCA mutation carriers, reducing the risk of cancer incidence while maintaining a high-level QOL.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.